In the case of putative SDHA mutations, the evidence for incomplete penetrance and lack of information on tumor risks in non‐probands suggests that the genetic testing and intensive surveillance of at risk family members will generally not be indicated until more information on the genetic epidemiology and age‐related tumor risks are available. This evidence concerns the gene SDHA and neoplasm.